400 women will use 'weed tampons' for Harvard cannabis study
They cost about $11 and contain 60mg of THC, the main psychoactive component of marijuana, and 10mg of CBD.
- A new observational study will ask 400 women to track their menstrual symptoms over the course of a few months during which they'll administer marijuana suppositories.
- Marijuana suppositories are designed to alleviate the pain and stress of periods.
- The observational study is described as a "first step," with the ultimate goal being a clinical trial that includes placebos.
Women have long used marijuana to alleviate the pain and stress of periods, though there's only anecdotal evidence showing the remedy actually works. An upcoming study hopes to change that by examining the potential benefits of "weed tampons," more accurately called marijuana suppositories.
What are marijuana suppositories?
Unlike traditional tampons that absorb menstrual blood, marijuana suppositories are designed only to help ease stress and pain from cramps, and therefore are seen as a replacement for conventional over-the-counter medications and narcotics. These suppositories have been on the market for years, though they've only been readily available in states where recreational marijuana is legal.
One suppository seller, California-based marijuana startup Foria Wellness, which also offers cannabis-infused lubricant, sprays and vaporizer pens, sells a vaginal suppository product called Relief. Each suppository costs about $11 and contains 60mg of THC, the main psychoactive component of marijuana, and 10mg of CBD, a non-psychoactive cannabinoid known for its pain-killing properties. The product has "minimal psychoactive effects," according to Foria.
Relief, which can be used alongside a traditional tampon, is made out of cocoa butter and dissolves shortly after insertion.
One customer wrote:
"Extremely easy to insert, I used a tampon applicator. The suppository looks like a mini missle and It smells like cookie dough and cocoa butter. After 20 minutes I begin feeling a lower sensation. It was very nice and relaxing. It relieved some pressure in my lower back, especially while laying on my stomach."
"I was visiting Colorado and in severe pain when someone suggested that I visit a dispensary and look for these. WOW! Literally saved my life. It was the first time in 7 years the muscles of my pelvis actually relaxed. The cramping after an hour was hardly noticeable and although TMI I was able to eliminate in a less painful way. These need to be LEGAL everywhere as they really are a medical intervention."
The largely positive response to marijuana suppositories like Relief helped inspire one Harvard researcher to pursue a first-of-its-kind study on the unconventional remedy.
An observational study on marijuana suppositories
Staci Gruber, a professor of psychiatry at Harvard Medical School and the director of the Cognitive and Clinical Neuroimaging Core and the Marijuana Investigations for Neuroscientific Discovery program, plans to conduct an observational survey of 400 women who will administer Foria's Relief suppositories over the course of a few months. The women will record their menstrual symptoms in an attempt to see if any correlative patterns emerge among the participants.
"What we're looking to do is take anecdotal information and turn it into data," Gruber told Business Insider, adding that the observational study, which will be funded by Foria and Flow Kana, is a first step and that a clinical trial would be the "holy grail".
However, studying marijuana treatments in clinical trials can be a long and difficult process because marijuana is still considered a Schedule 1 drug by the federal government. And though it'd be easier, from a legal perspective, for companies to sell (or pursue the study of) products containing only CBD (marijuana's non-psychoactive component), Foria CEO Mathew Gerson told Business Insider that the power of his products lies in the interactions between marijuana's multiple active compounds, a phenomenon known as the "entourage effect".
"We now know that the minute you break this plant apart into its component parts, you lose some of the magic," Gerson said. "And that sounds like hippie speak—but this is proven out again and again in study after study that the entourage effect as we understand it is real."
- A Harvard professor is asking 400 women to use 'weed tampons' as ... ›
- Cannabis Tampons: 4 Facts To Know, Including Pain And Anxiety ... ›
- Cannabis tampons: Women say cramps disappear within 20 ... ›
Former president of the ACLU Nadine Strossen discusses whether our society should always defend free speech rights, even for groups who would oppose such rights.
- Former ACLU president Nadine Strossen understands that protecting free speech rights isn't always a straightforward proposition.
- In this video, Strossen describes the reasoning behind why the ACLU defended the free speech rights of neo-Nazis in Skokie, Illinois, 1977.
- The opinions expressed in this video do not necessarily reflect the views of the Charles Koch Foundation, which encourages the expression of diverse viewpoints within a culture of civil discourse and mutual respect.
A new paradigm for machine vision has just been demonstrated.
- Scientists have invented a way for a sheet of glass to perform neural computing.
- The glass uses light patterns to identify images without a computer or power.
- It's image recognition at the speed of light.
A consortium of scientists and engineers have proposed that the U.S. and Mexico build a series of guarded solar, wind, natural gas and desalination facilities along the entirety of the border.
- The proposal was recently presented to several U.S. members of Congress.
- The plan still calls for border security, considering all of the facilities along the border would be guarded and connected by physical barriers.
- It's undoubtedly an expensive and complicated proposal, but the team argues that border regions are ideal spots for wind and solar energy, and that they could use the jobs and fresh water the energy park would create.
"A monkey has been able to control a computer with its brain," Musk said, referring to tests of the device.
- Neuralink seeks to build a brain-machine interface that would connect human brains with computers.
- No tests have been performed in humans, but the company hopes to obtain FDA approval and begin human trials in 2020.
- Musk said the technology essentially provides humans the option of "merging with AI."